Bioanalytical Menu
List of Assays
Vary by species, intended use and therapeutic areas.
The list shown below continues to grow and evolve. This list illustrates assay methods we offer and by no means is it our full capability.
Analyte(s) | Range | Validation Level | Anticoagulant | Species | Matrix | Intended Use | Therapeutic Area |
---|---|---|---|---|---|---|---|
Ritonavir | 10.0-10,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Immunology |
Ondansetron | 0.250 – 250 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Oncology |
Melatonin | 1.00-1,000 | Full Regulatory | NA | Human | Saliva | Pharmacokinetics; Biomarker | Neuroscience and Pain; Endocrine |
Simvastatin | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Simvastatin Hydroxy Acid | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Fentanyl | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Morphine | 0.200-50.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Oxycodone | 0.200-50.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Morphine-6-Gluc | 0.400-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ketoprofen | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma (H+) | Pharmacokinetics | Neuroscience and Pain |
(R)-Methadone | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
(S)-Methadone | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Nordiazepam | 0.500-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Clorazepate | 0.500-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Diclofenac | 0.100-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Atorvastatin | 50-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
2-Hydroxyatorvastatin | 20-20,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
4-Hydroxyatorvastatin | 20-20,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Hydrocodone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Hydromorphone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Norhydrocodone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Acetaminophen | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Rosuvastatin | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Pravastatin | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
(R)-Amphetamine | 0.200-200 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
(S)-Amphetamine | 0.200-200 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ropivacaine | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma (UF) | Pharmacokinetics | Neuroscience and Pain |
Ropivacaine | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Fentanyl | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ethinyl Estradiol | 7.50-7,500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Endocrine |
Norethindrone | 100-100,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Endocrine |
1MX | 100-100,000 | Full Regulatory | NA | Human | Urine (2Xcs) | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
AFMU | 100-100,000 | Full Regulatory | NA | Human | Urine (2Xcs) | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Isradipine | 0.100- 100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Metformin | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Anti-Insulin Ab | 100 – 1,000 | Full Regulatory | NA | Human | Serum | Pharmacokinetics | Cardiometabolic; Endocrine |
Midazolam | 0.1-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
1-OH Midazolam | 0.1-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Buproprion | 0.5-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
OH-Buproprion | 1-1000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Tolbutamide | 200-100,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
4-OH Tolbutamide | 2-1000 | Cardiometabolic | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Dextromethorphan | 0.1-50 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Dextrophan | 0.1-50 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Omeprazole | 2-1000 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
5-OH Omeprazole | 1-500 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Repaglinide | 0.0500-50 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
3-OH Repaglinide Diastereomer A | 0.0109-10.9 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
3-OH Repaglinide Diastereomer B | 0.0141-14.1 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Bupivacaine | 2-2,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Erythromycin | 0.0500 - 10.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Antimicrobial |
Insulin Lispro | 10.0 - 400 µU/mL | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic; Endocrine |
Moxifloxacin | 10.0 - 10,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Antimicrobial |
Analyte(s) | Range | Validation Level | Anticoagulant | Species | Matrix | Intended Use | Therapeutic Area |
---|---|---|---|---|---|---|---|
bST (bovine somatotropin) | 1.25-50 ng/mL | Research | NA | Bovine | Serum | Biomarker | Endocrine; Animal Health |
CA 19-9 | 200-0.274 U/mL | Research | NA | Human | Serum | Biomarker | Oncology |
CAIX | 500-31.3 pg/mL | Research | NA | Human | Serum | Biomarker | Oncology |
C-peptide | 19.1 - 1170 pM | Research | K2EDTA | Porcine | Plasma | Biomarker | Cardiometabolic; Endocrine |
CRP | 27.6-49608 pg/mL | Research | NA | Human | Serum | Biomarker | Cardiometabolic; Oncology; Immunology |
Haptoglobin | 0 - 50 µg/mL | Research | NA | Bovine | Serum | Biomarker | Cardiometabolic; Immunology |
IFN-alpha, IL-1 beta, IL-10, IL-12p70, IL-2, IL-4, IL-5, and TNF-alpha | Various | Qualified | NA | Mouse | Serum | Biomarker | Immunology |
IGF1 (insulin-like growth factor 1) | 0.312-20 ng/mL | Research | NA | Bovine | Serum | Biomarker | Endocrine |
IL-1 beta, IL-2, IL-12p70, TNF-alpha | Various | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
IL-12 | 30-10,000 pg/mL | Research | NA | Canine | Serum | Biomarker | Immunology |
IL-17 | 9.32-3653 pg/mL | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
IL-6 | 1.58-488 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
IL-8 | 1.13-375 pg/mL | Screening | NA | Bovine | Serum | Biomarker | Immunology |
Lipopolysaccharide Binding Protein | NA | Research | NA | Bovine | Serum | Biomarker | Immunology |
Myeloperoxidase | 0.312-20 ng/mL | Research | NA | Bovine | Serum | Biomarker | Cardiometabolic; Immunology |
Serum Amyloid A | 54.1-137,972 pg/mL | Research | NA | Bovine | Serum | Biomarker | Immunology |
TGF beta1 | 30-2000 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
TNF alpha | 0.69-248 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
TNF alpha | NA | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
VEGF | 7.70-784 pg/mL | Research | NA | Human | Serum | Biomarker | |
Caffeine | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain | |
Theobromine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
Paraxanthine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
Glutamine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
glutamate | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
pyroglutamic acid | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
glutamic acid | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
Glutathione | 200-200,000 ng/mL | Research | NA | Human | Serum | LC/MS | Cardiometabolic; Immunology |
Glutathione disulfide | NA | Research | NA | Human | Serum | LC/MS | Cardiometabolic; Immunology |
N-Acetyl-L-Cysteine | 10-1000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Glutathione | 200-20,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Cysteine | 10,000-1,000,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Homocysteine | 200-20,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Paclitaxel | 1-1,000 ng/mL | Research | K2EDTA | Human | Plasma | LC/MS | Oncology |